Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2021-10-26 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
2021年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "迪瑞医疗科技股份有限公司 2021 年第三季度报告" which translates to "Dirui Medical Technology Co., Ltd. 2021 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow analysis, shareholder information, and management commentary for the third quarter of 2021. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2021
2021-10-26 Chinese
第五届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Dirui Medical Technology Co., Ltd. It reports the approval of the 2021 third quarter report and a loan application proposal. The document includes voting results and meeting procedural details. It does not contain the actual financial report but references the third quarter report available on an external website. The document is short (712 characters) and serves as an announcement of board decisions rather than the report itself. Therefore, it fits best under Board/Management Information (MANG) as it announces board resolutions and management decisions.
2021-10-26 Chinese
2021年第三季度报告披露的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (282 characters) indicating that the full 2021 third quarter report has been published on the official disclosure website. It does not contain the actual financial data or substantive analysis itself, but rather directs investors to the full report. According to the 'MENU VS MEAL' rule, this is a report publication announcement, not the report itself.
2021-10-26 Chinese
第五届监事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Dirui Medical Technology Co., Ltd. regarding the approval of the company's 2021 third quarter report. It states that the Supervisory Board has reviewed and approved the 2021 Q3 report, confirming its compliance and accuracy. The document itself does not contain the financial statements or substantive financial data of the quarterly report but rather announces the approval and directs readers to the full report on an external website. The document length is short (672 characters), and it serves as an announcement of the report rather than the report itself. According to the 'Menu vs Meal' rule, this should be classified as a Regulatory Filing (RNS) because it is an official announcement related to a report but does not contain the report's content itself.
2021-10-26 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of invention patent certificates issued by the Chinese National Intellectual Property Administration. It details patent numbers, inventors, application dates, and the significance of the patents to the company's product lines. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, no voting results, no management changes, no legal proceedings, and no capital or financing updates. The document is a formal announcement about intellectual property achievements, which does not fit into any of the specific financial or corporate filing categories. Therefore, it falls under the fallback category of Regulatory Filings (RNS). The document length is short and it is not a report publication announcement or certification. Hence, the best classification is RNS with high confidence.
2021-10-22 Chinese
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates issued by a regulatory authority (Jilin Province Drug Administration). It lists product names, registration numbers, validity periods, and clinical uses. There is no financial data, no mention of financial results, no discussion of management changes, no voting results, no legal proceedings, and no mention of any report publication. The document is a regulatory announcement about product certifications, which does not fit into financial report categories like Annual Report, Interim Report, Earnings Release, or others. It is a regulatory filing announcing a non-financial regulatory approval. Therefore, the best fitting category is Regulatory Filings (RNS). The document length is short (2102 characters), and it is not an announcement of a report but a standalone announcement of regulatory approval.
2021-10-20 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.